Sethera Therapeutics, Inc.

Salt Lake City, UT

UEI
UPXWQBWXK1B9
CAGE
21YU1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
48 S Rio Grande St, Salt Lake City, UT 84101, USA
Website
setheratx.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Restoring mutant P53 function in tnbc using polymacrocyclic peptides HT9425261E422 Defense Health Agency $231,518

Quick answers

Is Sethera Therapeutics, Inc. registered in SAM.gov?

Yes. Sethera Therapeutics, Inc.'s SAM.gov registration is active through June 29, 2027.

What is Sethera Therapeutics, Inc.'s most recent federal award?

Sethera Therapeutics, Inc.'s most recent federal grant award is Restoring mutant P53 function in tnbc using polymacrocyclic peptides (HT9425261E422), from Defense Health Agency, on August 1, 2026.

On GovTribe

See Sethera Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login